Secondary monoclonal gammopathy after bone marrow autotransplantation as a cause of worse renal function in light chain immunoglobulin deposition disease
- Authors: Rekhtina IG1, Mendeleeva LP1, Stolyarevich ES2, Galtseva IV1, Povilaitite PE3, Biryukova LS1
-
Affiliations:
- Гематологический научный центр Минздрава России
- Московский государственный медико-стоматологический университет им. А.И. Евдокимова Минздрава России
- Патолого-анатомическое бюро
- Issue: Vol 88, No 6 (2016)
- Pages: 80-83
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32018
- ID: 32018
Cite item
Full Text
Abstract
About the authors
I G Rekhtina
Гематологический научный центр Минздрава РоссииМосква, Россия
L P Mendeleeva
Гематологический научный центр Минздрава РоссииМосква, Россия
E S Stolyarevich
Московский государственный медико-стоматологический университет им. А.И. Евдокимова Минздрава РоссииМосква, Россия
I V Galtseva
Гематологический научный центр Минздрава РоссииМосква, Россия
P E Povilaitite
Патолого-анатомическое бюроРостов, Россия
L S Biryukova
Гематологический научный центр Минздрава РоссииМосква, Россия
References
- Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, D’Agati VD, Leung N. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Clin J Am Soc Nephrol. 2012;7(2):231-239.
- Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, Dispenzieri A, Song KW, Kyle RA; International Kidney and Monoclonal Gammopathy Research Group. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012;120(22):4292-4295.
- Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand J-P, Picken MP, Herrera GA, Kastritis E, Merlini G, Roussel M, Fervenza FC, Dispenzieri A, Kyle RA, Nasr SH. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87:698-711.
- Fermand J-P, Bridoux F, Robert A, Kyle RA, Kastritis E, Weiss BM, Cook MA, Drayson MT, Dispenzieri A, Leung N. on behalf of the International Kidney and Monoclonal Gammopathy Research Group. How I treat monoclonal gammopathy of renal significance (MGRS). Blood. 2013;122:3583-3590.
- Bansal T, Hossain R, Mckane W, Snowden JA. Safety and efficacy of high dose melphalan and autologous stem cell transplantation prior to renal allograft in end-stage renal failure secondary to Monoclonal Immunoglobulin Deposition Disease. Cell Ther Transplant. 2011;10(3):1-4.
- Gertz MA. Managing light chain deposition disease. Leukemia Lymphoma. 2012;53(2):183-184.
- Leung N, Lager DJ, Gertz MA, Wilson K, Kanakiriya S, Fervenza FC. Long-term outcome of renal transplantation in light-chain deposition disease. Am J Kidney Dis. 2004;43:147-153.
- Weichman K, Dember LM, Prokaeva T, Wright DG, Quillen K, Rosenzweig M, Skinner M, Seldin DC, Sanchorawala V. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant. 2006;38(5):339-343.
- Telio D, Shepherd J, Forrest D, Zypchen L, Barnett M, Nevill T, Song KW. High-dose melphalan followed by ASCT has favorable safety and effi cacy in selected patients with light chain deposition disease and light and heavy chain deposition disease. Bone Marrow Transplant. 2012;47(3):453-455.
- Lorenz EC, Gertz MA, Fervenza FC, Dispenzieri A, Lacy MQ, Hayman SR, Gastineau DA, Leung N. Long-term outcome of autologous stem cell transplantation in light chain deposition disease. Nephrol Dial Transplant. 2008;23:2052-2057.
- Royer B, Arnulf B, Martinez F, Roy L, Flageul B, Etienne I, Ronco P, Brouet JC, Fermand JP. High dose chemotherapy in light chain or light and heavy chain deposition disease. Kidney Int. 2004;65(2):642-648.
- Harada K, Akai Y, Sakan H, Yamaguchi Y, Nakatani K, Iwano M, Saito Y. Resolution of mesangial light chain deposits 3 years after high-dose melphalan with autologous peripheral blood stem cell transplantation. Clin Nephrol. 2010;74(5):384-388.
- Рехтина И.Г., Голицина Е.П., Бирюкова Л.С. Нефропатия вследствие неамилоидных организованных и гранулярных депозитов как синдром множественной миеломы. Терапевтический архив. 2011;7:65-68.
- Wadhera RK, Kyle RA, Larson DR, Dispenzieri A, Kumar S, Lazarus HM, Rajkumar SV. Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma. Blood. 2011;118(11):2985-2987.
![](/img/style/loading.gif)